Table 2.
The miRNAs predicting the prognosis of ccRCC.
miRNA | Changes | Ref | Functional mechanism |
---|---|---|---|
miR-23B/27B | Downregulation | [14] | Inhibiting cell proliferation, migration, and invasion |
miR-29b | Upregulation | [15] | Promoting apoptosis; inhibiting cell proliferation and invasion by regulating the expression of KIF1B |
miR-124-3 | ND | [17] | In relation to cyclin D kinase 6 |
miR-27a-3p | Upregulation | [18] | Inhibiting cell proliferation, migration, and invasion |
miR-30a | Downregulation | [19] | Targeting DLL4 and decreasing tumor microvessel density |
miR-646 | Upregulation | [20] | Inhibiting cell proliferation and cell cycle by targeting NOB1 |
miR-30c | Upregulation | [21] | Regulating cell motility and adhesion |
miR-194 | Upregulation | [10] | Involved in ccRCC progression by targeting HIF1A, MDM2, PIK3R2, MAPK1, IGF1R, BCL2, ITGB1, and CRK |
miR-126 | Upregulation | [9] | Targeting SPRED1, IGF1R, BCL2, CRK, CCNE2, PIK3R2; involved in ccRCC progression through HIF-1, VEGF, mTOR, and PI3K–Akt signaling pathways |
mir-210 | Upregulation | [23] | Involved in mitochondrial metabolism, stem cell survival, cell cycle regulation, angiogenesis, and cell-cell adhesion |
miR-203 | Upregulation | [24] | Inhibiting cell proliferation, migration, and invasion by directly targeting FGF2 |
miR-217 | Upregulation | [27] | Inhibiting cell proliferation and migration |
miR-187 | Upregulation | [28] | Inhibiting cell proliferation, migration, and tumor growth by directly targeting B7-H3 |
miR-129-3p | Downregulation | [29] | Inhibiting cell migration and invasion by downregulating SOX4, p-FAK, MMP2, and MMP-9 |
miR-141-3p miR-145-5p |
Downregulation | [32] | Inhibiting cell migration by regulating HS6ST2 and LOX |